RxDoctor Payments Data

OSIA OSI300 IMPLANT: cost and payments to doctors

What Medicare Part D paid pharmacies for OSIA OSI300 IMPLANT, and the payments that named it as the associated device or medical supply under the Sunshine Act for program years 20192025.

Was your doctor paid by Cochlear Americas?

Cochlear Americas reported the most payments naming OSIA OSI300 IMPLANT. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$1.7M
Providers
1,644
Transactions
5,407
Average per transaction
$313

The per-transaction average — $313 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,644 providers the average total is $1,030, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Cochlear Americas$1,653,23897.6%
Cochlear Ltd$26,3131.6%
Nihon Cochlear Co Ltd$10,9440.6%
Cochlear Bone Anchored Solutions AB$2,9210.2%

Other products from Cochlear Americas

The company that reported the most payments naming OSIA OSI300 IMPLANT also reports against these.

← All drugs & devices